Phase I Studies of Recombinant Human Tumor Necrosis Factor in Patients with Malignant Disease

Autor:	H. Tilman Steinmetz, Michael Schaadt, Volker Diehl, Michael Pfreundschuh
Rok vydání:	2015
Předmět:	Necrosis CD30 Tumor necrosis factors business.industry Malignant disease law.invention Human tumor law Recombinant DNA Cancer research Medicine In patient medicine.symptom business
DOI:	10.1159/000415892
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d60b461b874568a15e7613c6c755e8c1 https://doi.org/10.1159/000415892 Zobrazit plný text záznamu